ロード中...
Aspirin attenuates YAP and β-catenin expression by promoting β-TrCP to overcome docetaxel and vinorelbine resistance in triple-negative breast cancer
The use of aspirin has been associated with reduced breast cancer risk, but it is litter known if aspirin overcomes chemoresistance in triple-negative breast cancer (TNBC). Herein, we demonstrated that changes in the expression of Yes-associated protein (YAP) and β-catenin might be a promising predi...
保存先:
| 出版年: | Cell Death Dis |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7359325/ https://ncbi.nlm.nih.gov/pubmed/32661222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-020-2719-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|